A multicenter, open‐label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non‐small cell lung cancer

BACKGROUND: Although the incidence of lung cancer in elderly individuals has been increasing in recent years, the number of clinical trials designed specifically for elderly patients with advanced non‐small cell lung cancer (NSCLC) is still limited. To fulfill this unmet medical need, we conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yabuki, Yohei, Hanibuchi, Masaki, Takeuchi, Eiji, Haku, Takashi, Kanematsu, Takanori, Nishimura, Naoki, Toyoda, Yuko, Mitsuhashi, Atsushi, Otsuka, Kenji, Sato, Seidai, Goto, Hisatsugu, Yoneda, Hiroto, Ogino, Hirokazu, Nokihara, Hiroshi, Tsutomu, Shinohara, Nishioka, Yasuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643789/
https://www.ncbi.nlm.nih.gov/pubmed/37718463
http://dx.doi.org/10.1111/1759-7714.15115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643789/
https://www.ncbi.nlm.nih.gov/pubmed/37718463
http://dx.doi.org/10.1111/1759-7714.15115

Ejemplares similares